Endurant Capital Management’s Krystal Biotech KRYS Stock Holding History

Endurant Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$1.2M	Buy
2019 Q2	–	Sell
2019 Q1	$2.01M	Buy
2018 Q4	$260K	Buy